JP Morgan Chase
TMDX icon

JP Morgan Chase’s Transmedics TMDX Stock Holding History

JP Morgan Chase’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.1M Sell
308,341
-66,920
-18% -$8.73M ﹤0.01% 1763
2025
Q4 		$45.7M Sell
375,261
-17,095
-4% -$2.15M ﹤0.01% 1427
2025
Q3 		$44M Sell
392,356
-71,885
-15% -$8.41M ﹤0.01% 1496
2025
Q2 		$62.2M Buy
464,241
+51,744
+13% +$5.68M ﹤0.01% 1198
2025
Q1 		$27.8M Buy
412,497
+155,671
+61% +$10.7M ﹤0.01% 1664
2024
Q4 		$16M Buy
256,826
+56,398
+28% +$5.25M ﹤0.01% 2242
2024
Q3 		$31.5M Sell
200,428
-14,365
-7% -$2.21M ﹤0.01% 1640
2024
Q2 		$32.4M Buy
214,793
+105,052
+96% +$12.6M ﹤0.01% 1504
2024
Q1 		$8.11M Sell
109,741
-6,624
-6% -$546K ﹤0.01% 2676
2023
Q4 		$9.18M Sell
116,365
-25,307
-18% -$1.53M ﹤0.01% 2570
2023
Q3 		$7.76M Buy
141,672
+30,486
+27% +$2.19M ﹤0.01% 2490
2023
Q2 		$9.34M Buy
111,186
+11,511
+12% +$881K ﹤0.01% 2340
2023
Q1 		$7.55M Buy
99,675
+67,753
+212% +$4.69M ﹤0.01% 2518
2022
Q4 		$1.97M Buy
31,922
+3,708
+13% +$197K ﹤0.01% 3569
2022
Q3 		$1.18M Sell
28,214
-38,513
-58% -$1.67M ﹤0.01% 3878
2022
Q2 		$2.1M Buy
66,727
+53,960
+423% +$1.44M ﹤0.01% 3507
2022
Q1 		$343K Buy
12,767
+2,591
+25% +$46.4K ﹤0.01% 4918
2021
Q4 		$194K Buy
10,176
+469
+5% +$11.8K ﹤0.01% 5380
2021
Q3 		$322K Sell
9,707
-316
-3% -$9.66K ﹤0.01% 4977
2021
Q2 		$332K Sell
10,023
-31,885
-76% -$884K ﹤0.01% 4954
2021
Q1 		$1.74M Sell
41,908
-19,717
-32% -$607K ﹤0.01% 3822
2020
Q4 		$1.23M Buy
61,625
+52,252
+557% +$773K ﹤0.01% 3821
2020
Q3 		$129K Sell
9,373
-2,389
-20% -$40.9K ﹤0.01% 4584
2020
Q2 		$210K Sell
11,762
-11,289
-49% -$177K ﹤0.01% 4237
2020
Q1 		$278K Buy
23,051
+13,988
+154% +$234K ﹤0.01% 4129
2019
Q4 		$172K Buy
9,063
+6,899
+319% +$127K ﹤0.01% 4730
2019
Q3 		$51K Buy
2,164
+351
+19% +$8.42K ﹤0.01% 5168
2019
Q2 		$50K Buy
+1,813
New +$49.5K ﹤0.01% 5169

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's TMDX Position: Q1 2026 in Review

JP Morgan Chase reduced its Transmedics (TMDX) stake by 18% in Q1 2026, selling an estimated $8.73M and leaving 308,341 shares worth $29.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

JP Morgan Chase first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $62.2M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • JP Morgan Chase held 308,341 shares of Transmedics worth $29.1M as of Q1 2026.
  • JP Morgan Chase sold 66,920 Transmedics shares in Q1 2026, an estimated $8.73M.
  • Transmedics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1763 holding.
  • JP Morgan Chase first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • JP Morgan Chase's Transmedics position peaked at $62.2M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.